Clinical data from the STEP trials shows clear dose-dependent increases in side effects
It cannot tell you the synthesis was clean, that the endotoxin is below a safe threshold, or that the unnamed contaminant that put six Victorians in hospital is absent, because nobody has even named that contaminant yet
Caffeine can be thought of as a middleman
In the 64-week OASIS 4 trial (307 adults with obesity or overweight, no diabetes), adherent participants on oral semaglutide 25 mg lost an average of 16.6% of body weight versus 2.7% for placebo (ScienceDaily/OASIS 4, 2025)
In their new study, Goss and his research partners analyzed data from UCHealth electronic health records and the Colorado All Payer Claims Database, which includes records on millions of public and private health insurance claims
The combination of GLP-1, GIP and/or GCG agonist actions with amylinthrough the incorporation of cagrisemaglutide or amicretinopens the door to the development of new multiagonists as treatments for obesity, type 2 diabetes, and possibly other chronic diseases